Evidence map›Paper›PMID 28492282›Full record

ArticleNature communications2017

Accumulation of heme biosynthetic intermediates contributes to the antibacterial action of the metalloid tellurite.

Eduardo H Morales, Camilo A Pinto, Roberto Luraschi, Claudia M Muñoz-Villagrán, Fabián A Cornejo, Scott W Simpkins, Justin Nelson, Felipe A Arenas, Jeff S Piotrowski, Chad L Myers and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Characterization of Tellurite Toxicity toInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. The Klebsiella pneumoniaeInfection and immunity · 2023
    Article
  8. Soft-metal(loid)s induce protein aggregation inFrontiers in microbiology · 2023
    Article
  9. Tolerance, Adaptation, and Cell Response Elicited byInternational journal of molecular sciences · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Eduardo H MoralesFacultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170022, Chile.
Camilo A PintoFacultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170022, Chile.
Roberto LuraschiFacultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170022, Chile.
Claudia M Muñoz-VillagránFacultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170022, Chile.
Fabián A CornejoFacultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170022, Chile.
Scott W SimpkinsUniversity of Minnesota-Twin Cities, Bioinformatics and Computational Biology, Minneapolis, Minnesota 55455, USA.
Justin NelsonUniversity of Minnesota-Twin Cities, Bioinformatics and Computational Biology, Minneapolis, Minnesota 55455, USA.
Felipe A ArenasFacultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170022, Chile.
Jeff S PiotrowskiYumanity Therapeutics, Cambridge, Massachusetts 02139, USA.
Chad L MyersUniversity of Minnesota-Twin Cities, Bioinformatics and Computational Biology, Minneapolis, Minnesota 55455, USA.
Hirotada MoriGraduate School of Biological Sciences, Nara Institute of Science and Technology, Ikoma 630-0101, Japan.
Claudio C VásquezFacultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170022, Chile.
Universidad de Santiago de Chile · CLUniversity of Minnesota · USNara Institute of Science and Technology · JPYumanity Therapeutics (United States) · US

Funding

TRAINING FOR FUTURE BIOTECHNOLOGY DEVELOPMENTT32GM008347 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SCHMIDT-DANNERT, CLAUDIA · 1990 to 2021
$11.0M
Mapping the reference genetic network of a eukaryotic cellR01HG005853 · NHGRI · UNIVERSITY OF TORONTO · PI ANDREWS, BRENDA JEAN, BOONE, CHARLES · 2010 to 2025
$7.6M
Methods for large-scale analysis of chemical-genetic interactionsR01HG005084 · NHGRI · UNIVERSITY OF MINNESOTA · PI MYERS, CHAD L · 2010 to 2022
$2.9M
Sparse Structural Equation Models for Gene Networks and Chemical GenomicsR01GM104975 · NIGMS · UNIVERSITY OF MIAMI CORAL GABLES · PI CAI, XIAODONG · 2012 to 2016
$1.8M
NHGRI NIH HHS R01 HG005084NHGRI NIH HHS R01 HG005853NIGMS NIH HHS R01 GM104975NIGMS NIH HHS T32 GM008347
6 · The paper itself

Abstract

The metalloid tellurite is highly toxic to microorganisms. Several mechanisms of action have been proposed, including thiol depletion and generation of hydrogen peroxide and superoxide, but none of them can fully explain its toxicity. Here we use a combination of directed evolution and chemical and biochemical approaches to demonstrate that tellurite inhibits heme biosynthesis, leading to the accumulation of intermediates of this pathway and hydroxyl radical. Unexpectedly, the development of tellurite resistance is accompanied by increased susceptibility to hydrogen peroxide. Furthermore, we show that the heme precursor 5-aminolevulinic acid, which is used as an antimicrobial agent in photodynamic therapy, potentiates tellurite toxicity. Our results define a mechanism of tellurite toxicity and warrant further research on the potential use of the combination of tellurite and 5-aminolevulinic acid in antimicrobial therapy.

Indexed as

Biosynthetic PathwaysAminolevulinic AcidAnti-Bacterial AgentsDrug Resistance, BacterialEscherichia coliGenome, BacterialHemeIron DeficienciesMetalloidsMicrobial Sensitivity TestsModels, BiologicalMutationProtoporphyrinsSuperoxidesTelluriumAminolevulinic AcidAnti-Bacterial AgentsHemeMetalloidsprotoporphyrin IXProtoporphyrinsSuperoxidesTelluriumtellurous acid

Identifiers

PMID28492282
PMCPMC5437285
OpenAlexW2612266855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.